Flutter therapy added to chest physiotherapy after CABG in COPD patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized controlled trial evaluates the effect of combining Flutter therapy with conventional chest physiotherapy versus conventional chest physiotherapy alone in adults with mild-to-moderate COPD undergoing elective CABG. Participants will be randomly assigned to receive 5 days of supervised postoperative treatment, with 3 sessions per day, starting 24–72 hours after surgery. The study aims to measure outcomes related to peak expiratory flow and chest expansion, among others. Normality testing and appropriate sample calculations were planned to ensure robust comparison between groups. The trial is conducted at Foundation University Islamabad, Rawalpindi, with 94 planned participants aged 40–70 years.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Adults aged 40-70 years undergoing elective CABG
* Pre-existing COPD (mild- moderate), clinically diagnosed COPD
* Early post-operative (24-72 hrs.), extubated and hemodynamically stable
* No mechanical ventilation beyond 24 hrs., stable vitals (HR: 60-100bpm, SBP :110-130mmhg), no vasopressors.
* Follow commands, provide consent and perform assessments.

Exclusion Criteria:

* Patients undergoing emergency CABG or revision/repeat CABG procedure
* Patients with severe COPD or intersitial lung disease
* Contraindications positive expiratoey pressure (PEP) therapy (e.g, untreated pneumothorax, hemoptysis or recent esophageal surgery).
* Hemodynamically unstable patients post-operatively.
* Patients with neurological, musculoskeletal or cognitive impairments.
* Patients with active infections, malignancy.
* Patients with severe or uncontrolled comorbidities(e.g; renal failure).
* Patients in BiPAP.

Where it's running

• Foundation University Islamabad
  Rawalpindi, Pakistan Recruiting

Study contacts

• Study coordinator: Kashaf Nadeem, MS-CPPT
• Email: kashafnadeem460@gmail.com
• Phone: +923349058792

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• TPB-based cadence exercise and breathing training for COPD patients

  A TPB-based program tests whether breathing training, cadence-guided walking, or both can improve lung function, exercise capacity, and quality of life in adults with COPD.

  Recruiting Fu Jen Catholic University Hospital · New Taipei City, New Taipei City and 1 other locations · NCT07860008

• See how dynamic chest X-rays relate to COPD patterns and progression risk

  This study looks at existing dynamic chest radiography data to see if new imaging measurements can identify COPD patterns, gauge severity, and predict who may experience faster progression.

  Recruiting Nanfang Hospital, Southern Medical University · Guangzhou, Guangdong · NCT07762573

• Personalized mobile app warnings to reduce COPD flares

  A personalized mobile app tests whether providing temperature-related risk warnings and protective tips, in addition to usual COPD care, can lower COPD flare-ups over 12 months.

  Recruiting at 4 sites Centers for Disease Control and Prevention, China · Beijing and 3 other locations · NCT07656142

• CLEAR model to predict when people with severe COPD can be taken off ventilatory support

  This project will see if the CLEAR model can predict which adults with severe COPD on invasive or non‑invasive ventilation can be safely taken off ventilatory support.

  Recruiting Assiut University · Asyut, Assuit Egypt · NCT07579052

• Long-term safety of Tozorakimab in COPD patients with prior exacerbations

  This study tests two long-term dosing regimens of tozorakimab in people with COPD who have a history of flare-ups and who completed earlier studies.

  Recruiting at 5 sites Phase 3 AstraZeneca · Aix-en-Provence and 12 other locations · NCT07566195

• SLC25A48 expression in COPD patients

  This study tests whether the mitochondrial choline transporter SLC25A48 is more or less active in people with COPD compared to healthy individuals and whether its levels relate to inflammation and choline metabolism.

  Recruiting Fu Jen Catholic University · New Taipei City and 1 other locations · NCT07474220

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.